Efficacy and Safety of a Single-Dose Mebendazole 500 mg Chewable, Rapidly-Disintegrating Tablet for Ascaris lumbricoides and Trichuris trichiura Infection Treatment in Pediatric Patients: A Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study

This randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of a new chewable, rapidly-disintegrating mebendazole (MBZ) 500 mg tablet for Ascaris lumbricoides and Trichuris trichiura infection treatment. Pediatric patients (1–15 years; N = 295; from Ethiopia and Rwanda)...

Descripción completa

Detalles Bibliográficos
Autores principales: Silber, Steven A., Diro, Ermias, Workneh, Netsanet, Mekonnen, Zeleke, Levecke, Bruno, Steinmann, Peter, Umulisa, Irenee, Alemu, Hailemaryam, Baeten, Benny, Engelen, Marc, Hu, Peter, Friedman, Andrew, Baseman, Alan, Mrus, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805036/
https://www.ncbi.nlm.nih.gov/pubmed/29016336
http://dx.doi.org/10.4269/ajtmh.17-0108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805036/
https://www.ncbi.nlm.nih.gov/pubmed/29016336
http://dx.doi.org/10.4269/ajtmh.17-0108

Ejemplares similares